Evaluation of diastolic function in hypertensive using echocardiography

Yamini Lavanya, Balaji Sharan Singh, Sajja Srikanth, Koneru Veer Raghava Choudary


Background: Heart failure is one of the most common causes of cardiovascular morbidity along with mortality and hypertension is the most common cause of cardiac failure. Recent studies have shown that isolated diastolic dysfunction very often accompanies hypertensive heart disease. Aims: The present study was conducted to identify the risk of cardiac failure in hypertensive individuals by evaluating diastolic function using mitral inflow velocities of echocardiography.

Methods: Subjects attending cardiology outpatient department for master health check up with age between 25 to 80 years were selected. The procedure was explained and consent was obtained from the subjects. All the subjects underwent a detailed clinical examination. Height, weight and blood pressure of the subjects was measured and BMI was calculated. Two-dimensional Doppler echocardiographic examinations were performed with an ultrasonographic system (Philips iE 133 Echo Doppler). The student t test, chi square test and logistic regression analysis were used to find the influence of ejection fraction and heart rate on diastolic function.

Results: The trans-mitral inflow parameters on Doppler echocardiography such as E wave deceleration time (DT), isovolumetric relaxation time (IVRT) and early to late transmitral peak flow velocities ratio (E/A) were significantly different in hypertensive subjects on treatment having normal ejection fraction, when compared to normotensive subjects. We observed a decrease in E/A ratio and increase in DT, IVRT with hypertension.

Conclusions: From the present study it can be concluded that hypertension is significantly associated with diastolic dysfunction of heart, even in subjects with normal systolic function.



Cardiac failure, Diastolic dysfunction, Echocardiography, Ejection fraction, Hypertension

Full Text:



Solomon SD, Janardhanan R, Verma A et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet. 2007;369:2079–87.

Aeschbacher BC, Hutter D, Fuhrer J, et al. Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens. 2001;14106–13.

Desai A. Current understanding of heart failure with preserved ejection fraction. Curr Opin Cardiol. 2007;22:578–85.

Bronzwaer JG, Paulus WJ. Matrix, cytoskeleton, or myofilaments: which one to blame for diastolic left ventricular dysfunction? Prog Cardiovasc Dis. 2005; 47(4):276–84.

Norton GR, Tsotetsi J, Trifunovic B et al. Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats. Circulation. 1997; 96(6):1991–8.

Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin–angiotensin–aldosterone system. Circulation. 1991;83:1849–65.

Susic D, Frohlich ED. The aging hypertensive heart: a brief update. Nat Clin Pract Cardiovasc Med. 2008;5(2):104–10.

Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194-202.

Rokey R, Kuo LC, Zoghbi WA, Limacher MC, Quinones MA. Determination of parameters of left ventricular diastolic filling with pulsed Doppler echocardiography: comparison with cineangiography. Circulation. 1985;71:543-50.

Spirito P, Maron BJ, Bonow RO. Non-invasive assessment of left ventricular diastolic function: comparative analysis of Doppler Echocardiographic and radionuclide angiographic techniques. J Am Coll Cardiol. 1986;7:518-26.

Zipes, Pathophysiology of Aging, In “Braun Wald’s heart disease a text book of cardiovascular medicine”, seventh edition, page: 1925-1946,187-210,457-507,653,1491-92.

Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C, Santucci A, Santucci C, Reboldi G and Porcellati C. Adverse prognostic significance of concentric remodelling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol. 1995;25(4);871-8.

Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographic ally determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-6.

Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114(5):345-52

Inouye I, Massie B, Loge D, Simpson P, Tubau JF. Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. Am J Cardiol. 1984;53(1);120-6.

Fouad FM, Slominsky JM, Tarazi RC. Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function. J Am Coll Cardiol 1984;3(6):1500-1506.

Solomon SD, Anavekar N, Skali H, et al. Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112:3738–44.

Galderisi M, Benjamin EJ, Evans JC, D'Agostino RB, Fuller DL, Lehman B et al. Intra- and inter-observer reproducibility of Doppler assessed indexes of left ventricular diastolic function in a population based study (the Framingham Heart Study). Am J Cardiol. 1992;70(15):1341-6.

Cesare Russo, Zhezhen Jin, Shunichi Homma, Tatjana Rundek, Mitchell S.V. Elkind, Ralph L. Sacco et al. Effect of diabetes and hypertension on left ventricular diastolic function in a high-risk population without evidence of heart disease. European Journal of Heart Failure. 2010;12(5):454-61.

Azad Akkoc, Berzal Ucaman, Halil Kaymak, Ali Vahip Temamogullari, Kenan Iltumur, Abdul-Aziz Karadede et al. Right and left ventricular diastolic filling parameters in essential hypertension. Asian Cardiovascular and Thoracic Annals. 1999;7:214-20.

Akintunde AA, Akinwusi PO, Opadijo OG, Adebayo RA, Ogunyemi SA. Prevalence of echocardiographic indices of diastolic dysfunction in patients with hypertension at a tertiary health facility in Nigeria. The Internet Journal of Cardiology 2008;6(2).

Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Journal of the American Society of Echocardiography. 2009;22(2):107-33.

Fred M. Kusumoto. Cardiovascular disorders: Heart disease. Stephen J Mcphee and William F. Ganong. In: “Pathophysiology of disease – an introduction to clinical medicine”, 7th edition, Mc Graw Hill companies, New Delhi, 2006, Ch10; Pg 276.

Rick A. Nishimura, Raymond J. Gibbons, James F. Glockner, A. Jamil Tajik. Non-invasive cardiac imaging: Echocardiography, nuclear cardiology, and MRI/CT imaging. Chapter-12, Kasper, Brraunwald, Fauci, Hauser, Longo, Jameson. In: “Harrison’s principles of internal medicine”, 16th Edn, vol – II, Mc Graw–Hill Companies, USA, 2005: 1320-1324.

de Simone G, Kitzman DW, Chinali M, Oberman A, Hopkins PN, Rao DC et al. Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study. Eur Heart J. 2005;26(10):1039-45.

Karabinos I, Grassos C, Kostaki P, Kranidis A. Echocardiography in the Evaluation of a Hypertensive Patient: An Invaluable Tool or Simply Following the Routine? Hellenic J Cardiol. 2013;54:47-57.

Ike SO, Ikeh VO. The prevalence of diastolic dysfunction in adult hypertensive Nigerian. Ghana Med J. 2006;40(2):55-60.

Angiomachalelis N, Hourzamanis AI, Sideri S et al. Improvement of left ventricular diastolic dysfunction in hypertensive patients. 1 month after ACE inhibition therapy. Heart Vessels. 1996;11(6):303-9.

De Mora MM, Aranda P, Barakat S. Diastolic dysfunction, left ventricular hypertrophy and micro albuminuria in mild to moderate essential arterial hypertension. Rev Esp Cardiol. 1997;50(4);233-8.

Mayet J, Shahi M, Poulter NR, Server PS, Foale RA, Thomas AM. Left ventricular diastolic function in hypertension: a 4 year follow-up study. Int J Cardiol. 1995;50(2):181-8.

Mitsunami K, Inoue S, Maeda K, Endoh S, Takahashi M, Okada M et al. Three month effects of candesartan cilexetil, an angiotensin II type 1 (AT1) receptor antagonist, on left ventricular mass and hemodynamic in patients with essential hypertension. Cardiovasc Drugs Ther. 1998;12(5);469-74.

Satpathy C, Trinath K, Satpathy R, Satpathy HK, Barone E. Diagnosis and management of diastolic dysfunction and heart failure. American Family Physician. 2006;73(5):841-6.